We are aware of increasing numbers of cases of Monkeypox present in the UK population.

If you have a sexual health concern AND have any of the following symptoms, please call our central booking line on 01904 721111 and one of our team will be able to get you the help you need.

Do not come directly to clinic if you have any of these symptoms:

  • Rash on any part of your body
  • Fever
  • New lump/s in neck, groin or under your arm


  1. Are you a gay, bisexual or other man who has sex with men?
  2. Have you had contact with someone with confirmed Monkeypox in the 21 days before symptom onset?
  3. Have you travelled to West and Central Africa, USA, Spain and Portugal in the 21 days before symptoms onset


We are unable to supply repeat contraceptive pills, patches and injections for those aged 20 and over these must be provided by your GP.

We can insert, exchange and remove implants and contraceptive coils for all ages and start all service users on a new form of contraception.

If you are experiencing severe pain and our clinics are closed please telephone NHS 111, for help and information 24 hours a day 365 days a year or attend the nearest A&E department. 

If you require Sexual health/Contraception care, please call our central booking line from 8:15am to 5pm Monday to Thursday and 8:15am to 3:30pm Friday and 9am to 12pm Saturday, on 01904 721111 and press option 1. 

Please note - we are not able to offer 'walk-in' services - all appointments need to be arranged through our booking team

Aged 17 or under? You can also text us on 07973 775692 to make an appointment Monday-Friday 8.15am-3:30pm. 

We kindly ask that you continue to wear face mask when you attend our clinics. 

If you are unable to speak on the phone for any other reason (i.e. hearing impairment or at risk within your home) you can email us on

No symptoms but want an STI screen? Please order a testing kit online:

For York

For North Yorkshire

Your GP may be able to help with your contraception needs.





For information on coronavirus (COVID-19), please visit


I would like to see current sexual health news

Most at risk populations - market engagement event

Yorsexual Health is keen to hear from partners working with people and communities who are at increased risk of sexual ill-health and inequalities. We are reviewing our models of care in the Yorkshire region and are exploring ways in which we can work with partners to improve health and wellbeing outcomes for these groups.

Want to find out more? You can register for our market engagement event taking place on the 18th January here:

BASHH Update - Needle Spiking in Nightclubs

There have been recent media reports of spiking by injection, where a person is allegedly “spiked” by an injection from an unknown source. This has typically been happening to young women attending nightclubs across the UK.
Sexual health services and the national Sexual Health helpline on 0300 123 7123 have recently seen an increase in enquiries from members of the public concerned about the potential risk of HIV and Blood Borne virus transmission due to needlestick injury.

BASHH has been contacted by several sexual health services from around the country about the risk of HIV and Blood borne virus transmission risks from needlestick injuries.
There have been no reports of HIV, Hepatitis B or Hepatitis C transmission from any of the incidents in the press.
BASHH advises that if patients attend medical services (Sexual Health Services, Emergency Department) they should be assessed for

1.    HIV Post-Exposure Prophylaxis (PEP) as per the BASHH guidelines
2.    Hepatitis B status and vaccination/prophylaxis if appropriate
3.    Hepatitis C testing at appropriate intervals (3 and 6 months)
The patient should also be referred to a local Sexual Assault Referral Centre (SARC) if appropriate.
In general, PEP is not recommended following a community needlestick exposure as the risk is extremely low and usually not possible to determine.  Whilst there have been a handful of cases of hepatitis B and C transmission from community needlestick, there have been no reported cases of HIV transmission.  

April 2020 - Coronavirus (Covid-19) guidance for professionals

The ADPH UK - COVID-19 guidance/ recommendations on the Prioritisation of Sexual & Reproductive Health Services has just been published, as four downloadable PDF docs.

FSRH advice for women seeking contraception, abortion and SRH advice during the COVID-19 pandemic

Please note current contraceptive advice includes:

Supported extended use of nexplanon to 4 years, mirena/levosert to 6 years and T-safe 380 to 12 years. Prescribing of combined hormonal contraception can be extended by up to 12 months if a woman has had a BP and BMI reading which was satisfactory within the last 12 months.

FPA/Sexwise unplanned pregnancy/abortion and Covid-19

BASHH support for local responses to COVID-19 and contingency planning

NHS Cervical Screening Programme Guidance for Sample Taking during Coronavirus pandemic

Sexwise Information for Professionals

Safe sex reminder as antibiotic resistant gonorrhoea investigations continue

Public Health England (PHE) is issuing a reminder to the public to practise safe sex by using a condom with new or casual partners.

The call comes as an increase in antibiotic resistant cases of gonorrhoea continues, a further sign of the very real threat of antibiotic resistance to our ability to treat infections.

Finding this sort of extensively drug resistant gonorrhoea in the UK serves as an important reminder of the need to practice safer sex. This includes using condoms consistently and correctly with all new and casual sexual partners. Anyone with symptoms of a sexually transmitted infection (STI) or who is concerned they may have an STI should seek advice from their sexual health clinic.

For more information visit

At the present time, the advice to frontline clinicians remains unchanged - as before we would still be advising all cases of suspected/confirmed gonorrhoea to be referred to local sexual health services for appropriate management, encouraging regular STI testing and protected sex with condoms.

Chlamydia treatment guidelines changed in September 2018


Chlamydia treatment guidelines changed in September 2018:

First line treatment is Doxycycline 100mg bd for seven days (contraindicated in pregnancy) and second line treatment is  Azithromycin 1g orally as a single dose, followed by 500mg once daily for two days

Publication of updated guideline for the management of infection with Neisseria gonorrhoeae (2019) The updated guideline for the management of infection with Neisseria gonorrhoeae is available at Changes since the 2011 guideline include: •    First line empirical treatment is now monotherapy with ceftriaxone 1g  •    If antimicrobial susceptibility test results from all sites of infection are available prior to treatment and the isolate is sensitive to ciprofloxacin, then this should be used for treatment in preference to ceftriaxone •    Recommendations for extra-genital testing in those with suspected or confirmed antimicrobial resistance  •    Epidemiological treatment is recommended only for those presenting within 14 days of exposure. For those presenting after 14 days of exposure we recommend treatment based on the results of testing.

The recent changes from the Neisseria gonorrhoeae, chlamydia treatment guidelines and the publication of BASHH Mycoplasma genitalium guidelines have impacted upon the first line treatment for Pelvic inflammatory disease, non-gonococcal urethritis. Please see BASHH website for the guidelines:


Combined Hormonal Contraception

The FSRH CHC Clinical Guideline is now available on the FSRH website

What is new in this guideline?

Latest news View all news


12th May 2022

DEVA study